Apyx Medical Corporation, a leader in surgical aesthetics, announced the commencement of an underwritten public offering of its common stock.
The offering is subject to market conditions with no assurance of completion or specific terms yet.
Lucid Capital Markets is the sole book-running manager for the offering.
Proposed Public Offering
Apyx Medical Corporation is initiating a public offering of shares, aiming to raise capital for business growth.
Underwritten Offering
The underwritten public offering is based on a shelf registration statement on Form S-3 filed with the SEC.
Market Conditions Impact
The offering is contingent on market conditions, indicating potential volatility in pricing and timing.
- The public offering reflects Apyx Medical Corporation's strategic approach to raising funds for expansion and innovation in the surgical aesthetics market.
- The involvement of Lucid Capital Markets as the book-running manager adds credibility and expertise to the offering process.
Apyx Medical Corporation's proposed public offering signifies a significant step towards supporting future growth and product development in the surgical aesthetics sector.